Accolade Analysis
| ACCDDelisted Stock | USD 7.02 0.00 0.00% |
Accolade is overvalued with Real Value of 5.93 and Hype Value of 7.02. The main objective of Accolade delisted stock analysis is to determine its intrinsic value, which is an estimate of what Accolade is worth, separate from its market price. There are two main types of Accolade's stock analysis: fundamental analysis and technical analysis.
The Accolade stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Accolade's ongoing operational relationships across important fundamental and technical indicators.
Accolade |
Accolade Stock Analysis Notes
About 88.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.84. Some equities with similar Price to Book (P/B) outperform the market in the long run. Accolade has Price/Earnings To Growth (PEG) ratio of 1.91. The entity recorded a loss per share of 2.28. The firm had not issued any dividends in recent years. Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Accolade operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2350 people. For more info on Accolade please contact Rajeev Singh at 206 926 8100 or go to https://www.accolade.com.Accolade Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Accolade's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Accolade or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Accolade is not yet fully synchronised with the market data | |
| Accolade has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 414.29 M. Net Loss for the year was (99.81 M) with profit before overhead, payroll, taxes, and interest of 215.08 M. | |
| Accolade currently holds about 330.63 M in cash with (16.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6. | |
| Over 88.0% of the company shares are held by institutions such as insurance companies |
Accolade Upcoming and Recent Events
| 25th of April 2024 Upcoming Quarterly Report | View | |
| 4th of July 2024 Next Financial Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View | |
| 25th of April 2024 Next Fiscal Year End | View | |
| 30th of November 2023 Last Quarter Report | View | |
| 28th of February 2023 Last Financial Announcement | View |
Accolade Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 575.59 M.Accolade Profitablity
The company has Profit Margin (PM) of (0.4) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.23) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.23.Accolade Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Accolade insiders, such as employees or executives, is commonly permitted as long as it does not rely on Accolade's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Accolade insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Accolade Outstanding Bonds
Accolade issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Accolade uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Accolade bonds can be classified according to their maturity, which is the date when Accolade has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Accolade Predictive Daily Indicators
Accolade intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Accolade stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Accolade Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Accolade prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Accolade shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Accolade. By using and applying Accolade Stock analysis, traders can create a robust methodology for identifying Accolade entry and exit points for their positions.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Accolade operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2350 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Accolade to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Accolade Stock
If you are still planning to invest in Accolade check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accolade's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |